DrugPatentWatch Database Preview
Details for Patent: 10,292,990
» See Plans and Pricing
Which drugs does patent 10,292,990 protect, and when does it expire?
Patent 10,292,990 protects YONSA and is included in one NDA.
This patent has fifty patent family members in twenty-five countries.
Summary for Patent: 10,292,990
Title: | Abiraterone steroid formulation |
Abstract: | A nanoparticulate composition of abiraterone acetate that allows treatment at a lower dose than convention abiraterone acetate formulations is described as in a method of treating prostate cancer by administering the composition together with a glucocorticoid. |
Inventor(s): | Nemeth; Paul (Philadelphia, PA), Callahan; Matt (Penn Valley, PA), Bosch; H. William (Bryn Mawr, PA), Norret; Marck (Darlington, AU) |
Assignee: | SUN PHARMA GLOBAL FZE (Sharjah, AE) |
Application Number: | 15/345,410 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 10,292,990
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharma Global | YONSA | abiraterone acetate | TABLET;ORAL | 210308-001 | May 22, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,292,990
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 095480 | Start Trial | |||
Australia | 2014232508 | Start Trial | |||
Australia | 2015317466 | Start Trial | |||
Australia | 2018241103 | Start Trial | |||
Brazil | 112015023629 | Start Trial | |||
Brazil | 112017003219 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |